| Indicators | Browse All

Stereotaxis, Inc. (STXS)

Healthcare | Medical Instruments & Supplies | Saint Louis, United States | NYSE American
1.45 USD -0.02 (-1.361%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 1.45

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 1:29 a.m. EDT

Despite a 'strong buy' analyst recommendation and a positive long-term price trajectory, Stereotaxis presents a dangerous value trap for investors. The company is burning cash aggressively with negative operating margins and shrinking revenue, resulting in a massive hole in the balance sheet. While the stock has rallied significantly over the last decade, the most recent annual performance was flat, and the immediate future looks bleak with no dividend to cushion the blow. The options market confirms this pessimism, with traders stacking put contracts and refusing to write calls, signaling a high probability of further downside. The disconnect between the optimistic analyst targets and the deteriorating operational reality suggests the market is pricing in a severe restructuring or failure, making this a speculative gamble rather than a sound investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.104691
AutoARIMA0.121414
AutoETS0.121415
MSTL0.129646

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 41%
H-stat 1.72
Ljung-Box p 0.000
Jarque-Bera p 0.274
Excess Kurtosis -0.75
Attribute Value
Sector Healthcare
Debt to Equity Ratio 29.599
Revenue per Share 0.311
Market Cap 145,293,152
Forward P/E -9.35
Beta 1.40
Profit Margins -74.24%
Website https://www.stereotaxis.com

As of Aug. 22, 2026, 1:29 a.m. EDT: Speculators are overwhelmingly bearish, positioning heavy in-the-money puts while offering virtually no call protection. The open interest is concentrated entirely in downside strikes, suggesting a consensus expectation of further price weakness rather than a rally.


Info Dump

Attribute Value
52 Week Change -0.4575646
Address1 710 North Tucker Boulevard
Address2 Suite 110
All Time High 154.0146
All Time Low 0.47
Ask 1.47
Ask Size 2,000
Audit Risk 9
Average Analyst Rating 1.3 - Strong Buy
Average Daily Volume10 Day 543,530
Average Daily Volume3 Month 827,866
Average Volume 827,866
Average Volume10Days 543,530
Beta 1.403
Bid 1.46
Bid Size 800
Board Risk 7
Book Value 0.125
City Saint Louis
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 8
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.45
Current Ratio 1.418
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 1.49
Day Low 1.44
Debt To Equity 29.599
Display Name Stereotaxis
Earnings Call Timestamp End 1,786,480,200
Earnings Call Timestamp Start 1,786,480,200
Earnings Timestamp 1,786,478,400
Earnings Timestamp End 1,794,859,200
Earnings Timestamp Start 1,794,859,200
Ebitda -18,058,000
Ebitda Margins -0.60056996
Enterprise To Ebitda -8.041
Enterprise To Revenue 4.829
Enterprise Value 145,209,152
Eps Current Year -0.21
Eps Forward -0.155
Eps Trailing Twelve Months -0.24
Esg Populated 0
Exchange ASE
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1.5322
Fifty Day Average Change -0.08219993
Fifty Day Average Change Percent -0.053648304
Fifty Two Week Change Percent -45.75646
Fifty Two Week High 3.59
Fifty Two Week High Change -2.1399999
Fifty Two Week High Change Percent -0.5961003
Fifty Two Week Low 1.24
Fifty Two Week Low Change 0.21000004
Fifty Two Week Low Change Percent 0.16935487
Fifty Two Week Range 1.24 - 3.59
Financial Currency USD
First Trade Date Milliseconds 1,092,317,400,000
Float Shares 65,540,241
Forward Eps -0.155
Forward P E -9.354839
Free Cashflow -8,830,500
Full Exchange Name NYSE American
Full Time Employees 131
Fullday Change -0.02
Fullday Change Percent -1.36054
Fullday Price 1.45
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,785,542,400
Gross Margins 0.55567
Gross Profits 16,708,000
Has Pre Post Market Data 1
Held Percent Insiders 0.21149
Held Percent Institutions 0.43783
Implied Shares Outstanding 100,202,178
Industry Medical Instruments & Supplies
Industry Disp Medical Instruments & Supplies
Industry Key medical-instruments-supplies
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,383,523,200
Last Split Factor 1,096:1000
Long Business Summary Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Long Name Stereotaxis, Inc.
Market us_market
Market Cap 145,293,152
Market State CLOSED
Max Age 86,400
Message Board Id finmb_34778
Most Recent Quarter 1,782,777,600
Net Income To Common -23,587,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 147,297,201
Number Of Analyst Opinions 3
Open 1.48
Operating Cashflow -15,290,000
Operating Margins -0.59556997
Overall Risk 8
Payout Ratio 0.0
Peg Ratio 1.31
Phone 314 678 6100
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 1.45
Post Market Time 1,787,959,804
Previous Close 1.47
Price Eps Current Year -6.9047623
Price Hint 4
Price To Book 11.6
Price To Sales Trailing12 Months 4.8321524
Profit Margins -0.74241996
Quick Ratio 0.909
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.33333
Region US
Regular Market Change -0.02
Regular Market Change Percent -1.36054
Regular Market Day High 1.49
Regular Market Day Low 1.44
Regular Market Day Range 1.44 - 1.49
Regular Market Open 1.48
Regular Market Previous Close 1.47
Regular Market Price 1.45
Regular Market Time 1,787,947,200
Regular Market Volume 288,126
Return On Assets -0.25379
Return On Equity -1.84267
Revenue Growth -0.128
Revenue Per Share 0.311
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 7
Shares Outstanding 100,202,178
Shares Percent Shares Out 0.0537
Shares Short 5,384,782
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 4,458,474
Short Name Stereotaxis, Inc.
Short Percent Of Float 0.0635
Short Ratio 4.21
Source Interval 15
State MO
Symbol STXS
Target High Price 3.0
Target Low Price 3.0
Target Mean Price 3.0
Target Median Price 3.0
Total Cash 10,491,000
Total Cash Per Share 0.105
Total Debt 5,173,000
Total Revenue 30,068,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.24
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.98255
Two Hundred Day Average Change -0.53255
Two Hundred Day Average Change Percent -0.26861867
Type Disp Equity
Volume 288,126
Website https://www.stereotaxis.com
Zip 63,101